A&P LIFESCIENCE FUND, FI · 80 posiciones
| 2,68 % |
Seattle Genetics Inc US81181C1045 | 2,49 % |
Lilly (Eli) & Co. US5324571083 | 2,05 % |
Biostar Pharmaceutic US09061G1013 | 2,00 % |
Mirati Therapeutics US60468T1051 | 1,96 % |
Descom Inc US87164F1057 | 1,95 % |
AllogeneTherapeutics US0197701065 | 1,95 % |
Axsome Therapeutics US05464T1043 | 1,93 % |
Legend Biotech Corp US52490G1022 | 1,93 % |
Genmab A/S US3723032062 | 1,92 % |
ARGENX SE US04016X1019 | 1,89 % |
Agios Pharmaceutical US00847X1046 | 1,78 % |
Amgen Inc. US0311621009 | 1,70 % |
IncytCor US45337C1027 | 1,58 % |
Arcus Biosciences In US03969F1093 | 1,47 % |
CRISPR Therapeutics CH0334081137 | 1,33 % |
Sarepta Therapeutics US8036071004 | 1,24 % |
Sangamo Therapeutics US8006771062 | 1,23 % |
Nkarta Inc US65487U1088 | 1,20 % |
Arvinas Inc US04335A1051 | 1,18 % |
Pliant Therapeutics US7291391057 | 1,12 % |
Thermo Electron Corp US8835561023 | 1,09 % |
ROCHE HOLDING US7711951043 | 1,07 % |
Affimed NV NL0010872420 | 1,04 % |
GlycoMimetics Inc US38000Q1022 | 1,03 % |
Aura Biosciences Inc US05153U1079 | 1,03 % |
AnaptysBio Inc US0327241065 | 1,01 % |
Abbott Laboratories US0028241000 | 0,98 % |
AbbVie Inc US00287Y1091 | 0,95 % |
Accs. Boston Scienti US1011371077 | 0,93 % |
Regeneron Pharmaceut US75886F1075 | 0,92 % |
Xencor Inc US98401F1057 | 0,92 % |
Medtronic INC IE00BTN1Y115 | 0,90 % |
Aclaris Therapeutics US00461U1051 | 0,88 % |
Beigene ltd-adr US07725L1026 | 0,88 % |
Morphosys AG DE0006632003 | 0,87 % |
NOVARTIS AG-REG SHS US66987V1098 | 0,83 % |
ALX Oncology Holding US00166B1052 | 0,79 % |
Anavex Life Sciences US0327973006 | 0,77 % |
Bluebird Bio Inc US09609G1004 | 0,74 % |
ADC Therapeutics SA CH0499880968 | 0,73 % |
Penumbra Inc US70975L1070 | 0,72 % |
Guardant Health Inc US40131M1099 | 0,72 % |
Bioxcel Therapeutics US09075P1057 | 0,72 % |
Innate Pharma SA US45781K2042 | 0,68 % |
Adaptimmune Therapeu US00653A1079 | 0,67 % |
Exact Sciences Corp US30063P1057 | 0,64 % |
iTeos Therapeutics I US46565G1040 | 0,64 % |
Biomea Fusion Inc US09077A1060 | 0,63 % |
Foghorn Therapeutics US3441741077 | 0,61 % |
Clovis Oncology Inc US1894641000 | 0,59 % |
Replimune Group Inc US76029N1063 | 0,56 % |
Ayala Pharmaceutical US05465V1089 | 0,56 % |
BioAtla Inc US09077B1044 | 0,54 % |
Ideaya Biosciences I US45166A1025 | 0,53 % |
Arrowhead Pharmaceut US04280A1007 | 0,45 % |
Illumina Inc US4523271090 | 0,43 % |
Keros Therapeutics I US4923271013 | 0,42 % |
ImmunoGen Inc US45253H1014 | 0,40 % |
Fate Therapeutics In US31189P1021 | 0,37 % |
Magenta Therapeutics US55910K1088 | 0,36 % |
Relay Therapeutics I US75943R1023 | 0,35 % |
Autolus Therapeutics US05280R1005 | 0,33 % |
Poseida Therapeutics US73730P1084 | 0,32 % |
Edit-Me US28106W1036 | 0,28 % |
Cardiff Oncology Inc US14147L1089 | 0,20 % |
Bicycle Therapeutics US0887861088 | 0,19 % |
Ikena Oncology Inc US45175G1085 | 0,10 % |
Passage Bio Inc US7027121000 | 0,10 % |
Inventiva SACA US46124U1079 | 0,10 % |
Compugen Ltd IL0010852080 | 0,09 % |
MacroGenics Inc US5560991094 | 0,00 % |
Turning Point Therap US90041T1088 | 0,00 % |
Vascular Biogenics L IL0011327454 | 0,00 % |
Nektar Therapeutics US6402681083 | 0,00 % |
Alector Inc US0144421072 | 0,00 % |
Landos Biopharma Inc US5150691021 | 0,00 % |